Press release
Immunomodulator Market Growth Rate, Latest Trends, Industry Insights And Forecast To 2033
Immunomodulator Market Growth
As per the report, the immunomodulator market size has grown strongly in recent years. It will grow from $204.37 billion in 2023 to $219.94 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The immunomodulator market size is expected to see strong growth in the next few years. It will grow to $297.15 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15591&type=smp
Rise In Chronic Diseases Fueling The Growth Of The Immunomodulator Market
The rise in chronic diseases is expected to propel the growth of the immunomodulator market. Chronic diseases are long-lasting medical conditions that typically develop gradually over time and persist for extended periods, often lasting for years or even a lifetime. Chronic diseases are becoming more common due to a multitude of interconnected variables, such as an aging population, lifestyle decisions, genetic predispositions, and the accessibility and infrastructure of healthcare. Immunomodulators provide valuable therapeutic options for managing chronic diseases by modulating immune responses, reducing inflammation, preventing organ rejection, enhancing immune surveillance, and improving symptom control. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rise in chronic diseases is driving the growth of the immunomodulator market.
Innovative Non-Immunosuppressive Immunomodulators Lead Revenue Growth In Major Companies
Companies operating in the immunomodulator market are focused on the development of non-immunosuppressive products to address the growing demand for treatments that offer targeted immune modulation without compromising the body's overall immune function. Non-immunosuppressive refers to treatments or substances that do not suppress or weaken the immune system's response. For instance, in February 2024, Nuvig Therapeutics, Inc., a US-based biotechnology company, initiated early-stage clinical trials for NVG-2089, a next-generation immune modulator. NVG-2089 is a proprietary product designed to treat patients with inflammatory myopathies and severe dermatologic autoimmune diseases. The FDA has granted fast-track designation for NVG-2089's development in bullous pemphigoid. This novel, recombinant, non-immunosuppressive immunomodulator targets type II Fc receptors to trigger an endogenous regulatory mechanism that reduces autoimmune dysregulation. The study's primary objective is to assess the safety and tolerability of NVG-2089, with secondary objectives focusing on pharmacokinetics and pharmacodynamics.
The immunomodulator market covered in this report is segmented -
1) By Product Type: Immunosuppressants, Immunostimulants, Other Product Types
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Oncology, Respiratory, Human Immunodeficiency Virus, Other Applications
4) By End-User: Hospitals, Clinics, Other End Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @ https://www.thebusinessresearchcompany.com/Discount?id=15591&type=discount
Major companies operating in the immunomodulator market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Sanofi S.A, Bristol Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Applied Molecular Genetics Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Horizon Therapeutics plc, Incyte Corporation, Ipsen SA, Kyowa Kirin Co. Ltd., Amicus Therapeutics Inc.
Contents of the report:
1. Executive Summary
2. Immunomodulator Market Report Structure
3. Immunomodulator Market Trends And Strategies
4. Immunomodulator Market - Macro Economic Scenario
5. Immunomodulator Market Size And Growth
…..
27. Immunomodulator Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunomodulator Market Growth Rate, Latest Trends, Industry Insights And Forecast To 2033 here
News-ID: 3561389 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Immunomodulator
Rise In Chronic Diseases Fueling The Growth Of The Immunomodulator Market: An Em …
The Immunomodulator Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Immunomodulator Market?
The immunomodulator market size has grown strongly in recent years. It will grow from $219.94 billion in 2024 to $237.71 billion in 2025 at a compound annual…
Prominent Immunomodulator Market Trend for 2025: Innovative Non-Immunosuppressiv …
What Are the Projected Growth and Market Size Trends for the Immunomodulator Market?
In recent times, the size of the immunomodulator market has shown significant expansion. It is projected to balloon from a worth of $219.94 billion in 2024 to an impressive $237.71 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. The notable growth in the historical phase can be credited to factors such as the enhancement…
Immunomodulator Market to Hit USD 178 Billion by 2034 at a 7.2% of CAGR
As chronic diseases such as cancer and autoimmune disorders reach unprecedented levels globally, the demand for immunomodulators is surging. Future Market Insights' newly updated report projects the global immunomodulator market to grow significantly, with an estimated valuation of USD 88.6 billion in 2024. Immunomodulators, which regulate or normalize the immune system's response, are increasingly pivotal in modern medical treatments, making them a cornerstone of efforts to address these complex diseases.
The…
Global Immunomodulator Market Growth Opportunities, And Future Prospects (2024-2 …
"The Business Research Company recently released a comprehensive report on the Global Immunomodulator Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The immunomodulator market size has grown…
2022-2028 Cancer Immunomodulator Market | Detailed Report
Global Cancer Immunomodulator Market 2022-2028, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5390502
The report provides a…
Cancer Immunomodulator Market 2017 - AbGenomics Corporation, Baxter Internationa …
A market study based on the "Cancer Immunomodulator Market" across the globe, recently added to the repository of Market Research, is titled ‘Global Cancer Immunomodulator Market 2017’. The research report analyses the historical as well as present performance of the worldwide Cancer Immunomodulator industry, and makes predictions on the future status of Cancer Immunomodulator market on the basis of this analysis.
Get Free Sample Copy of Report Here : https://goo.gl/6QZZJJ
Top Manufacturers…
